Table 1.
Classification of cases based on IMP3 immunoreactivity patterns
| PARAMETER | IMP3 weakly positive or negative | IMP3 moderately or strongly positive | P VALUE |
|---|---|---|---|
| Number of cases | 17 | 33 | |
| Age (years) | 67.6 | 67.9 | 0.9 |
| Stage at Presentation (n) | |||
| Uterus Confined disease (FIGO stage I and II) | 11 | 16 | 0.37 |
| Extrauterine Disease (FIGO stage III and IV) | 6 | 17 | |
| Lymphovascular invasion present (n) | 7 | 15 | 0.8 |
| Myometrial invasion | |||
| Average (%) | 7.6 | 12.3 | 0.25 |
| ≤50% (n) | 10 | 19 | 1 |
| >50% (n) | 7 | 13 | |
| Unknown | 0 | 1 | |
| Lymph nodes obtained and status known (n) | 13 | 27 | |
| positive | 2 | 8 | 0.46 |
| negative | 11 | 19 | |
| Mitotic Index | 4 | 4.7 | 0.7 |
| Architectural Gradeb | |||
| A and B | 14 | 17 | 0.01 |
| C | 2 | 17 | |
| Relapses/Recurrencesa | |||
| Number of cases with follow-up | 12 | 31 | 0.23 |
| No of cases with relapses/recurrences | 1 | 10 | |
a
For cases with follow-up
b
Architectural grade by Yamamoto et al criteria (10)